Targeted Deletion of Fibroblast Growth Factor 23 Rescues Metabolic Dysregulation of Diet-induced Obesity in Female Mice
Endocrinology · 2024
DOI: 10.1210/endocr/bqae141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2024. Verfasst von Min Young Park und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathobiology, New York University College of Dentistry, New York, NY 10010, USA. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Obesity, Fibroblast Growth Factor-23, Diet, High-Fat. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, American Heart Association, VA BLR&D.
Abstract (Originalsprache)
Fibroblast growth factor 23 (FGF23) is a bone-secreted protein widely recognized as a critical regulator of skeletal and mineral metabolism. However, little is known about the nonskeletal production of FGF23 and its role in tissues other than bone. Growing evidence indicates that circulating FGF23 levels rise with a high-fat diet (HFD) and they are positively correlated with body mass index (BMI) in humans. In the present study, we show for the first time that increased circulating FGF23 levels in obese humans correlate with increased expression of adipose Fgf23 and both positively correlate with BMI. To understand the role of adipose-derived Fgf23, we generated adipocyte-specific Fgf23 knockout mice (AdipoqFgf23Δfl/Δfl) using the adiponectin-Cre driver, which targets mature white, beige, and brown adipocytes. Our data show that targeted ablation of Fgf23 in adipocytes prevents HFD-fed female mice from gaining body weight and fat mass while preserving lean mass but has no effect on male mice, indicating the presence of sexual dimorphism. These effects are observed in the absence of changes in food and energy intake. Adipose Fgf23 inactivation also prevents dyslipidemia, hyperglycemia, and hepatic steatosis in female mice. Moreover, these changes are associated with decreased respiratory exchange ratio and increased brown fat Ucp1 expression in knockout mice compared to HFD-fed control mice (Fgf23fl/fl). In conclusion, this is the first study highlighting that targeted inactivation of Fgf23 is a promising therapeutic strategy for weight loss and lean mass preservation in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pathobiology, New York University College of Dentistry, New York, NY 10010, USA.
- Endocrine Research Unit, Department of Medicine, San Francisco Department of Veterans Affairs Medical Center, University of California San Francisco, San Francisco, CA 94158, USA.
- Holman Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.
- Department of Nutritional Sciences, Rutgers University, New Brunswick, NJ 08901, USA.
- Department of Medicine, Rutgers-RWJ Medical School, New Brunswick, NJ 08903, USA.
- Department of Medicine, Division of Cardiology, NYU Langone Health Cardiovascular Research Center, New York University Grossman School of Medicine, New York, NY 10016, USA.
ORCID-Profile: Chia-Ling Tu, Wenhan Chang, Despina Sitara
Förderung
- NIDDK NIH HHS
- American Heart Association
- VA BLR&D
- BLRD VA
- NIAMS NIH HHS
- Doris Duke Charitable Foundation
- NIA NIH HHS
- NIH HHS
Zitieren
APA
Park, M. Y., Tu, C. L., Perie, L., Verma, N., Serdan, T. D. A., Shamsi, F., Shapses, S., Heffron, S., Gamallo-Lana, B., Mar, A. C., Alemán, J. O., Mueller, E., Chang, W., & Sitara, D. (2024). Targeted Deletion of Fibroblast Growth Factor 23 Rescues Metabolic Dysregulation of Diet-induced Obesity in Female Mice. Endocrinology. https://doi.org/10.1210/endocr/bqae141
Vancouver
Park MY, Tu CL, Perie L, Verma N, Serdan TDA, Shamsi F, et al. Targeted Deletion of Fibroblast Growth Factor 23 Rescues Metabolic Dysregulation of Diet-induced Obesity in Female Mice. Endocrinology. 2024. doi:10.1210/endocr/bqae141
BibTeX
@article{Park2024,
author = {Park, Min Young and Tu, Chia-Ling and Perie, Luce and Verma, Narendra and Serdan, Tamires Duarte Afonso and Shamsi, Farnaz and Shapses, Sue and Heffron, Sean and Gamallo-Lana, Begona and Mar, Adam C and Alemán, José O and Mueller, Elisabetta and Chang, Wenhan and Sitara, Despina},
title = {Targeted Deletion of Fibroblast Growth Factor 23 Rescues Metabolic Dysregulation of Diet-induced Obesity in Female Mice},
journal = {Endocrinology},
year = {2024},
doi = {10.1210/endocr/bqae141}
}
EUVIMED